These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3719582)

  • 1. Treatment of advanced gastric carcinoma with mitomycin and doxorubicin.
    Dalley D; Erlichman C; Fine S
    Cancer Treat Rep; 1986 Jul; 70(7):897-8. PubMed ID: 3719582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
    Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS
    Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC).
    De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
    Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
    Hagin GD; Jain A
    Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.
    Itoh T; Sakata Y; Tamura Y; Furukohori N; Saitoh S; Suzuki H; Tsushima K; Munakata A; Yoshida Y; Takagi S
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1551-6. PubMed ID: 2509606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined UFTM for 140 patients with advanced gastric cancer].
    Jin ML
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM).
    Faedi M; Amadori M; Gentilini P; Ridolfi R; Ravaioli A; Amadori D; Biserni R; Bonaguri C
    Chemioterapia; 1986 Aug; 5(4):240-3. PubMed ID: 3769045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
    Repetto L; Campora E; Nobile MT; Rosso R
    G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
    Bouillet T; Lepage E; Gisselbrecht C; Boiron M
    Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of adriamycin, mitomycin-C, and tegafur (AMF) chemotherapy on advanced lung cancer].
    Nabeshima K; Iwahashi N; Fujii J; Tamura S; Hada T; Higashino K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1487-90. PubMed ID: 2990352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with mitomycin C, adriamycin and cisplatin (MAP) in advanced adenocarcinoma of the lung: clinical effect and renal toxicity].
    Fujii M; Kiura K; Okabe K; Toki H
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):105-8. PubMed ID: 3099647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
    Adachi M; Sasaki M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2856-7. PubMed ID: 3092746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of adenocarcinoma of the stomach].
    Zeitoun P; Lirzin P
    Ann Gastroenterol Hepatol (Paris); 1984; 20(4):213-7. PubMed ID: 6442117
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
    Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
    Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
    Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
    Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
    Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
    Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
    Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.